AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $127.10
- 52-wk high
- $132.60
- High
- $129.80
- 52-wk low
- $81.09
- Low
- $126.71
- Prev close
- $128.47
Smart money
Earnings
Earnings came in 59.1% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.37B | $1.51B | $1.27B | $1.67B |
| Cost of what it sold | $99.0M | $121.1M | $104.5M | $105.0M |
| Gross profit | $1.27B | $1.39B | $1.17B | $1.57B |
| What it spent | ||||
| Research and development | $506.6M | $611.4M | $515.9M | $517.0M |
| Sales and admin | $329.1M | $390.4M | $328.1M | $351.7M |
| Total operating expenses | $835.7M | $1.00B | $844.0M | $871.2M |
| What was left | ||||
| Operating profit | $431.3M | $384.0M | $324.2M | $697.9M |
| Interest on debt | $592.0K | $582.0K | $569.0K | $581.0K |
| Profit before tax | $482.3M | $389.9M | $343.6M | $751.5M |
| Tax | $58.1M | $90.7M | $40.3M | $165.9M |
| Net profit | $424.2M | $299.3M | $303.3M | $585.6M |
| EBITDA | $506.9M | $414.5M | $368.0M | $752.1M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
70balanced
20D volatility
42%annualized
52-week range
$81.09$132.60
20D support
News
What the news says
38 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Incyte Corp's R&D Head Pablo J. Cagnoni Sells 10,801 Shares via 10b5-1 Trading Plan
Leans bearishAug 20Incyte (INCY) R&D head sells 10,801 shares, holds 183,200 in awards
Leans bearishAug 20H.C. Wainwright reiterates Incyte stock rating on cancer trial data
BullishAug 20